SILVERSMITH CAPITAL PARTNERS

Thesis

Silversmith Capital Partners is a Boston-based growth equity firm founded in 2015, specializing in investments within the technology and healthcare sectors. The firm focuses on partnering with founders and entrepreneurs to scale their businesses, emphasizing long-term relationships, strategic guidance, and a values-driven approach. Their investment strategy centers on identifying and supporting profitable, high-growth companies that have moved beyond early-stage venture risk, primarily targeting companies in Software-as-a-Service (SaaS) & Information Services and Healthcare Information Technology & Services. They seek businesses with strong revenue growth, scalable business models, and established commercial traction. Their approach is characterized by a "calculated risk" mindset, leveraging extensive experience to make swift, high-conviction investments when they identify promising opportunities. The firm's geographic scope is primarily the United States. As of July 2025, Silversmith Capital Partners closed its fifth fund, Fund V, with $1.7 billion in total commitments, bringing the firm's total capital commitments to over $5 billion. Their AUM was reported as $3.3 billion in late 2024, and also stated as over $5 billion in mid-2025. Fund V will make minority and majority investments in growth-stage tech and healthcare companies, with deals in the range of more than $100 million being common. For healthcare technology, Silversmith will invest $15 million to $50 million.

Related lists

• Series C+ Enterprise investors
• Series C+ Healthcare investors
• Series C+ investors based in Boston, MA